Physician profile
Joseph Farmer
NPI 1760485403
$7,204.30
in general payments reported to CMS, 2019-2025
40 companies · $2,360 in 2025
The $2,360 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,078 · 2020: $203 · 2022: $382 · 2023: $1,480 · 2024: $1,701 · 2025: $2,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,541.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $900.76 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $772.83 | 2019-2025 | |
| Lilly USA, LLC | $702.14 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $697.45 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $573.47 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $481.32 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $313.03 | 2023-2025 | Rexulti |
| Amgen INC. | $295.47 | 2019-2025 | Repatha, Otezla, Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $285.43 | 2023-2025 | |
| Glaxosmithkline, LLC. | $271.33 | 2019-2025 | Trelegy Ellipta, Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $250.77 | 2019-2025 | Xifaxan |
| Amarin Pharma, INC. | $152.26 | 2019-2023 | |
| Dexcom, INC. | $149.63 | 2022-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $134.64 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.19 | 2019-2024 | Synjardy, Tradjenta, Jardiance |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $111.56 | 2023-2024 | Gvoke Hypopen |
| Exact Sciences Corporation | $108.31 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $97.80 | 2024-2025 | |
| Astellas Pharma US INC | $84.93 | 2023-2025 | Veozah |
| Abiomed | $65.67 | 2024-2025 | Impella |
| Phathom Pharmaceuticals, INC. | $56.67 | 2024-2025 | Voquezna |
| Eisai INC. | $53.22 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $52.41 | 2019-2025 | Eliquis, Camzyos |
| Intra-Sana Laboratories | $52.25 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Edwards Lifesciences Corporation | $49.40 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $46.10 | 2019-2023 | Xarelto |
| Boston Scientific Corporation | $43.23 | 2019-2025 | Watchman Flx |
| Allergan, INC. | $42.88 | 2019-2020 | |
| Daiichi Sankyo INC. | $39.15 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $29.53 | 2019 | |
| Esperion Therapeutics, INC. | $24.91 | 2022 | |
| Inspire Medical Systems, INC. | $19.70 | 2025 | Inspire |
| Hikma Pharmaceuticals USA | $18.90 | 2019 | |
| Medtronic, INC. | $18.40 | 2025 | Intellis Adaptivestim |
| Scilex Pharmaceuticals INC. | $18.03 | 2019 | |
| Insmed, INC. | $14.60 | 2019 | |
| Lundbeck LLC | $13.44 | 2023 | Rexulti |
| Idorsia Pharmaceuticals US INC | $13.30 | 2023 | Quviviq |
| Sanofi Pasteur INC. | $12.84 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Farmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.